Medicare Part D Prescription Claims for Tofacitinib and Baricitinib, 2017-2021
Skinmed
.
2024 Dec 31;22(6):486-489.
eCollection 2024.
Authors
Lina Alhanshali
1
,
Jerry Shapiro
2
,
Kristen Lo Sicco
3
Affiliations
1
SUNY Downstate College of Medicine, Brooklyn, NY.
2
Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY.
3
Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY; kristen.losicco@nyulangone.org.
PMID:
39748589
No abstract available